0000000001246531

AUTHOR

Meritxell Canals

0000-0002-7942-5006

showing 1 related works from this author

The Life Cycle of the Mu-Opioid Receptor

2020

Opioid receptors (ORs) are undisputed targets for the treatment of pain. Unfortunately, targeting these receptors therapeutically poses significant challenges including addiction, dependence, tolerance, and the appearance of side effects, such as respiratory depression and constipation. Moreover, misuse of prescription and illicit narcotics has resulted in the current opioid crisis. The mu-opioid receptor (MOR) is the cellular mediator of the effects of most commonly used opioids, and is a prototypical G protein-coupled receptor (GPCR) where new pharmacological, signalling and cell biology concepts have been coined. This review summarises the knowledge of the life cycle of this therapeutic …

media_common.quotation_subjectBioinformaticsBiochemistry03 medical and health sciences0302 clinical medicineMediatorAnimalsMedicineReceptorMolecular Biology030304 developmental biologymedia_commonG protein-coupled receptorLife Cycle Stages0303 health sciencesbusiness.industryAddictionDrug ToleranceAnalgesics OpioidOpioidReceptors Opioidμ-opioid receptorbusiness030217 neurology & neurosurgeryBiogenesismedicine.drugTrends in Biochemical Sciences
researchProduct